The dual specificity PI3K/mTOR inhibitor PKI-587 displays...

Cancer Letters 2017 / 04 Vol. 392

The dual specificity PI3K/mTOR inhibitor PKI-587 displays efficacy against T-cell acute lymphoblastic leukemia (T-ALL)

Gazi, Mohiuddin, Moharram, Sausan A., Marhäll, Alissa, Kazi, Julhash U.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
392
Language:
english
Journal:
Cancer Letters
DOI:
10.1016/j.canlet.2017.01.035
Date:
April, 2017
File:
PDF, 3.39 MB
english, 2017
Conversion to is in progress
Conversion to is failed